Endovascular Treatment of Aortic Arch Vessel Stent Migration: Three Case Reports

2019 ◽  
Vol 59 ◽  
pp. 313.e11-313.e17 ◽  
Author(s):  
Zakariyae Bouziane ◽  
Sergueï Malikov ◽  
Serge Bracard ◽  
Laurent Fouilhé ◽  
Ludovic Berger ◽  
...  
2003 ◽  
Vol 10 (4) ◽  
pp. 728-732 ◽  
Author(s):  
Peter Waldenberger ◽  
Gustav Fraedrich ◽  
Ammar Mallouhi ◽  
Werner R. Jaschke ◽  
Reinhold Perkmann ◽  
...  

2013 ◽  
Vol 24 (1) ◽  
pp. 33-39 ◽  
Author(s):  
Ivonne Wieland ◽  
Thomas Jack ◽  
Kathrin Seidemann ◽  
Martin Boehne ◽  
Florian Schmidt ◽  
...  

AbstractArterial thrombosis in neonates and children is a rare event and is often associated with external risk factors such as asphyxia or sepsis. We report our experiences with two neonates with spontaneous aortic arch thrombosis mimicking aortic coarctation. Despite single case reports until now, no data exist for the underlying thrombophilic risk factors and prognosis of this rare event. Both patients were carriers of a heterozygous factor V Leiden mutation, which has been reported once before as a risk factor for aortic arch thrombosis. One of our patients was operated upon successfully and is alive. The second patient suffered a large infarction of the right medial cerebral artery and had a thrombotic occlusion of the inferior caval vein. The patient obtained palliative care and died at the age of 6 days. In the literature, we identified 19 patients with neonatal aortic arch thrombosis. Of the 19 patients, 11 (58%) died. Including the two reported patients, the mortality rate of patients with multiple thromboses was 80% (8/10) compared with 18% (2/11) for patients with isolated aortic arch thrombosis; this difference reached statistical significance (p = 0.009). The analysis of thrombophilic disorders revealed that factor V Leiden mutation and protein C deficiency seem to be the most common risk factors for aortic arch thrombosis.Conclusion:Neonatal aortic arch thrombosis is a very rare but life-threatening event, with a high rate of mortality, especially if additional thrombotic complications are present. Factor V Leiden mutation seems to be one important risk factor in the pathogenesis of this fatal disease.


2018 ◽  
Vol 53 ◽  
pp. 14
Author(s):  
Aude Grognet ◽  
Antoine Millon ◽  
Fadi Farhat (CHU Lyon) ◽  
Jean-Pierre Favre ◽  
Manuela Cherchi ◽  
...  

Angiología ◽  
2021 ◽  
Author(s):  
Matteo Pizzamiglio ◽  
Ciro Baeza Bermejillo ◽  
Alejandro González García ◽  
Valeria Carolina Arízaga Idrovo ◽  
César Aparicio Martínez

Author(s):  
Nikolaos Konstantinou ◽  
Tilo Kölbel ◽  
Eike S. Debus ◽  
Fiona Rohlffs ◽  
Nikolaos Tsilimparis

2020 ◽  
Vol 12 (4) ◽  
pp. 1437-1448 ◽  
Author(s):  
Chang Shu ◽  
Bowen Fan ◽  
Mingyao Luo ◽  
Quanming Li ◽  
Kun Fang ◽  
...  

2019 ◽  
Vol 70 (5) ◽  
pp. e155
Author(s):  
Mohammed Natour ◽  
Jonathan Lorber ◽  
Ralf Kolvenbach ◽  
Ron Karmeli

Surgery Today ◽  
2009 ◽  
Vol 40 (1) ◽  
pp. 54-56 ◽  
Author(s):  
Kazuyuki Daitoku ◽  
Ikuo Fukuda ◽  
Satoshi Taniguchi ◽  
Masahito Minakawa

Sign in / Sign up

Export Citation Format

Share Document